Medac Pharma develops and commercializes mid-to-late stage molecule therapies for the treatment of autoimmune diseases and cancer. Read more

33 Followers on Owler
33 Followers on Owler
33 Followers on Owler
33 Followers on Owler

Medac Pharma develops and commercializes mid-to-late stage molecule therapies for the treatment of autoimmune diseases and cancer. Read more

CEO Avatar

CEO

Update CEO

CEO Approval Rating

- -/100

TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Celsius Therapeutics has been one of Medexus Pharma, Inc.'s top competitors. Celsius Therapeutics is a Private company that was founded in 2018 in Cambridge, Massachusetts. Like Medexus Pharma, Inc., Celsius Therapeutics also competes in the Biotechnology sector. Compared to Medexus Pharma, Inc., Celsius Therapeutics has 23 fewer employees.

Opsona is seen as one of Medexus Pharma, Inc.'s biggest rivals. Opsona is a Private company that was founded in Dublin, County Dublin in 2004. Like Medexus Pharma, Inc., Opsona also operates in the Biotechnology sector. Opsona has 30 fewer employees vs. Medexus Pharma, Inc..

Evox is perceived as one of Medexus Pharma, Inc.'s biggest rivals. Evox was founded in Oxford, England} in 2016. Like Medexus Pharma, Inc., Evox also competes in the Biotechnology space. Compared to Medexus Pharma, Inc., Evox generates $9.6M more revenue.

Weigh-in!

Help the Owler community know more

Growth Score - 1/1

Is 55 a good estimate for Medexus Pharma, Inc.'s Employee count?

Acquisitions

No recent acquisitions found related to Medexus Pharma, Inc.

Medexus Pharma, Inc. Funding History

No recent funding data found related to Medexus Pharma, Inc.

Investments

No recent investments found related to Medexus Pharma, Inc.

Medexus Pharma, Inc. News

December 1, 2015MedicalMarketing& Media

Medac hires HCB to promote RA drug

The drugmaker's lead product, Rasuvo, is an injectable version of a commonly prescribed drug used to ... See more »
May 21, 2015BIOPORTFOLIO

Medac Pharma Inc. Fasttracks Successful U.S. Launch of Rasuvo with Veeva Commercial Cloud

In less than four months Medac Pharma establishes bestinclass commercial operation with complete suit... See more »
April 16, 2015PHARMACEUTICAL PROCESSING

Medac Pharma Announces Settlement Of Patent Infringement Lawsuits

Medac Pharma, Inc., a privately-held pharmaceutical company, today announced that it and its parent c... See more »
November 24, 2014SYS-CON MEDIA

Medac Pharma, Inc. Brings Motion to Preliminarily Prohibit Antares Sales of Otrexup to New Patients

CHICAGO, Nov. 24, 2014 /PRNewswire/ -- Medac Pharma, Inc., a privately held pharmaceutical company, t... See more »
July 14, 2014BIOSPACE

Medac Pharma, Inc. Wins FDA Approval Of Rasuvo Injection For Rheumatoid Arthritis, Poly-Articular-Course Juvenile Idiopathic Arthritis And Psoriasis

/www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup" ALT"free biotech news">/enewsle... See more »
May 15, 2014BIOSPACE

Medac Pharma, Inc. Announces Successful FDA Inspection Of Its Exclusive Methotrexate Manufacturer

/www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup" ALT"free biotech news">/enewsle... See more »
April 16, 2014PHARMACEUTICAL BUSINESS REVIEW

Medac Pharma gets FDA approval for trade name Rasuvo for injectable MTX product

US-based pharmaceutical firm Medac Pharma has received approval from the US Food and Drug Administrat... See more »

Medexus Pharma, Inc. Press Releases

October 6, 2014PR NEWSWIRE

Medac Pharma, Inc.'s Rasuvo (methotrexate) injection Now Available for Patients With Rheumatoid Arthritis, Poly-Articular-Course Juvenile Idiopathic Arthritis and Psoriasis

­­CHICAGO, Oct. 6, 2014 /PRNewswire/ -- Medac Pharma, Inc., a privately held pharmaceutical company, ... See more »
July 14, 2014PR NEWSWIRE

Medac Pharma, Inc. Secures FDA Approval of Rasuvo (methotrexate) injection for Rheumatoid Arthritis, Poly-Articular-Course Juvenile Idiopathic Arthritis and Psoriasis

CHICAGO, July 14, 2014 /PRNewswire/ -- Medac Pharma, Inc., a privately held pharmaceutical company fo... See more »
May 14, 2014PR NEWSWIRE

Medac Pharma, Inc. Announces Successful FDA Inspection Of Its Exclusive Methotrexate Manufacturer

CHICAGO, May 14, 2014 /PRNewswire/ -- Medac Pharma, Inc., a privately held pharmaceutical company foc... See more »

Social Media

Headquarters

29 North Wacker Drive Suite 704

Chicago, Illinois60606

312-854-0500

Driving Directions »

Trending Companies

Summary

ABOUT

Overview

Medac Pharma develops and commercializes mid-to-late stage molecule therapies for the treatment of autoimmune diseases and cancer. Medexus Pharma, Inc. was founded in 2012. Medexus Pharma, Inc.'s headquarters is located in Chicago, Illinois, USA 60606...

Website

medacpharma.com

Frequently Asked Questions about Medexus Pharma, Inc.

  1. When was Medexus Pharma, Inc. founded?

    Medexus Pharma, Inc. was founded in 2012
  2. How much revenue does Medexus Pharma, Inc. generate?

    Medexus Pharma, Inc. generates $3.4M in revenue
  3. How much funding does Medexus Pharma, Inc. have?

    Medexus Pharma, Inc. has historically raised $0 in funding
  4. Where is Medexus Pharma, Inc.'s headquarters?

    Medexus Pharma, Inc.'s headquarters is in Chicago Illinois, USA
  1. How many employees does Medexus Pharma, Inc. have?

    Medexus Pharma, Inc. has 55 employees
  2. What sector does Medexus Pharma, Inc. operate in?

    Medexus Pharma, Inc. is in Pharmaceuticals, Biotechnology
  3. Who are Medexus Pharma, Inc.'s competitors?

    Medexus Pharma, Inc.'s top competitors are Celsius Therapeutics, Opsona, Evox